TCT 2010 roundup

September 22, 2010 by MassDevice staff

Medical device makers are flocking to this year's Transcatheter Cardiovascular Therapeutics conference in Washington, D.C., eager to tout the results of clinical trials and new products to some 12,000 cardiologists and other healthcare professionals.

TCT2010, stent wars logo

A major battlefield in the stent wars opens again this week, as thousands of cardiologists and other healthcare providers flock to Washington, D.C., for the annual Transcatheter Cardiovascular Therapeutics conference.

Medical device industry players large and small are busy hawking the results of clinical trials and touting new products — or new versions of older products. TCT 2010, which kicked off yesterday, is slated to run through Sept. 25.

Here's a quick look at some of this year's offerings from Abbott (NYSE:ABT), Boston Scientific Corp. (NYSE:BSX), Medtronic Inc. (NYSE:MDT), Johnson & Johnson's (NYSE:JNJ) Cordis Corp.,St. Jude Medical Inc. (NYSE:STJ), Cardiovascular Systems Inc. (NSDQ:CSII) and Corindus Vascular Robotics Inc.: